SCHEMBL7966058

SCHEMBL7966058

NC(=O)c1cccc2c1c1c(OCC(=O)O)cc(C(F)(F)F)cc1n2Cc1c(F)cc(F)cc1F

nearest known ligand 0.40

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 14/20 0.40
PLA2G1B P04054 6/20 0.36
PLA2G10 O15496 3/20 0.36
PLA2G5 P39877 3/20 0.36
PLA2G2E Q9NZK7 3/20 0.36
PTGDR2 Q9Y5Y4 4/20 0.36
PLA2G6 O60733 1/20 0.35
PLA2G2C Q5R387 1/20 0.35
PLA2G12B Q9BX93 1/20 0.35
PLA2G12A Q9BZM1 1/20 0.35
PLA2G2F Q9BZM2 1/20 0.35
PLA2G3 Q9NZ20 1/20 0.35
PLA2G2D Q9UNK4 1/20 0.35
RORC P51449 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30410857 0.82 PLA2G2A (0.49) PLA2G2APLA2G1BPLA2G10PLA2G5PLA2G2E
SCHEMBL817427 0.82 PLA2G2A (0.49) PLA2G2APLA2G1BPLA2G10PLA2G5PLA2G2E
SCHEMBL29862795 0.79 PLA2G2A (0.52) PLA2G2APLA2G1BPLA2G10PLA2G5PLA2G2E
SCHEMBL819532 0.79 PLA2G2A (0.52) PLA2G2APLA2G1BPLA2G10PLA2G5PLA2G2E
SCHEMBL7969476 0.78 PLA2G2A (0.42) PLA2G2APLA2G1BPLA2G10PLA2G5PLA2G2E
SCHEMBL7955179 0.78 PLA2G2A (0.52) PLA2G2APLA2G1BPLA2G10PLA2G5PLA2G2E
SCHEMBL818875 0.78 PTPN1 (0.48) PLA2G2APLA2G1BPLA2G10PLA2G5PLA2G2E
SCHEMBL29862383 0.78 PTPN1 (0.48) PLA2G2APLA2G1BPLA2G10PLA2G5PLA2G2E
SCHEMBL7965981 0.77 PLA2G2A (0.49) PLA2G2APLA2G1BPLA2G10PLA2G5PLA2G2E
SCHEMBL7955041 0.77 PLA2G2A (0.49) PLA2G2APLA2G1BPLA2G10PLA2G5PLA2G2E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6177440-B1 THERAPY FOR SEPSIS SHOCK; PHOSPHOLIPASE INHBITOR ELI LILLY AND COMPANY 2001-01-23 US disclosed